USANA Health Sciences, Inc. Common Stock (USNA)
19.20
+0.30 (1.59%)
NYSE· Last Trade: Jun 23rd, 6:12 PM EDT
Detailed Quote
| Previous Close | 18.90 |
|---|---|
| Open | 18.93 |
| Bid | 16.52 |
| Ask | 19.98 |
| Day's Range | 18.93 - 19.40 |
| 52 Week Range | 16.60 - 38.32 |
| Volume | 64,692 |
| Market Cap | 368.41M |
| PE Ratio (TTM) | 21.82 |
| EPS (TTM) | 0.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 116,575 |
Chart
About USANA Health Sciences, Inc. Common Stock (USNA)
Usana Health Sciences Inc is a company that specializes in the development and manufacturing of nutritional supplements, personal care products, and energy sports products. Focused on promoting health and well-being, Usana combines science with quality in its offerings, delivering products that support a balanced lifestyle. The company markets its products through a direct selling model, engaging a network of independent distributors to reach consumers globally. Usana is committed to research and innovation, ensuring its formulations meet high standards of efficacy and safety while catering to a diverse range of health and wellness needs. Read More
News & Press Releases
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via StockStory · June 23, 2026
USANA currently trades at $18.88 per share and has shown little upside over the past six months, posting a small loss of 4.1%. The stock also fell short of t...
Via StockStory · June 22, 2026
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including e.l....
Via StockStory · June 21, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · June 8, 2026
USANA Health Sciences (NYSE:USNA) Q1 Earnings Beat Triggers After-Hours Rallychartmill.com
Via Chartmill · May 5, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · June 4, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · June 1, 2026
Let’s dig into the relative performance of Herbalife (NYSE:HLF) and its peers as we unravel the now-completed Q1 personal care earnings season. While persona...
Via StockStory · May 28, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care sto...
Via StockStory · May 17, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via StockStory · May 13, 2026
USANA’s first quarter saw steady performance, with revenue flat year-over-year and a positive market reaction following results that surpassed Wall Street ex...
Via StockStory · May 12, 2026
USANA (USNA) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 6, 2026
Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2026 results topping the market’s revenue expectations, but sales were f...
Via StockStory · May 5, 2026
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026.
By USANA Health Sciences, Inc. · Via Business Wire · May 5, 2026
What Happened? A number of stocks fell in the afternoon session after the oil price surge raised input cost concerns for an industry (personal care) that rel...
Via StockStory · May 4, 2026
Health and wellness products company USANA Health Sciences (NYSE:USNA) will be reporting results this Tuesday after market close. Here’s what to look for. US...
Via StockStory · May 3, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...
Via StockStory · April 26, 2026
USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2026 results will be released after the close of market on Tuesday, May 5, 2026. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, May 6, 2026 at 11:00 a.m. Eastern Time.
By USANA Health Sciences, Inc. · Via Business Wire · April 15, 2026
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over t...
Via StockStory · April 6, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · March 24, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · March 13, 2026
USANA Health Sciences, Inc. (NYSE: USNA) today announced that the Company will participate in the following upcoming conferences:
By USANA Health Sciences, Inc. · Via Business Wire · March 2, 2026
What a brutal six months it’s been for USANA. The stock has dropped 32.2% and now trades at $21.47, rattling many shareholders. This might have investors contemplating their next move.
Via StockStory · March 1, 2026
USANA’s fourth quarter results met Wall Street’s expectations on revenue and surpassed estimates for non-GAAP profit, yet the market responded negatively. Management attributed this to ongoing margin pressures and a continued shift in business mix, particularly the growing role of lower-margin brands like Rise Wellness and Hiya. CEO Kevin Guest, who resumed his leadership role, highlighted operational changes and a strategic pivot toward omnichannel distribution and scientific product innovation. He acknowledged headwinds, saying, “Our core business has faced year-over-year sales declines, but we are seeing encouraging signs of stabilization.”
Via StockStory · February 24, 2026
Shares of health and wellness products company USANA Health Sciences (NYSE:USNA)
fell 8.8% in the afternoon session after the company's fourth-quarter 2025 earnings report highlighted a significant drop in profitability, overshadowing beats on headline revenue and profit estimates.
Via StockStory · February 18, 2026